Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus

Autor: Wilding, John P.H., Rigney, Una, Blak, Betina T., Nolan, Stephen T., Fenici, Peter, Medina, Jesús

Publikováno v: In Diabetes Research and Clinical Practice September 2019 155

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study

Autor: Kosiborod, Mikhail, Cavender, Matthew A., Fu, Alex Z., Wilding, John P., Khunti, Kamlesh, Norhammar, Anna, Birkeland, Kåre, Jørgensen, Marit Eika, Holl, Reinhard W., Lam, Carolyn SP, Gulseth, Hanne Løvdal, Carstensen, Bendix, Bollow, Esther, Franch-Nadal, Josep, García Rodríguez, Luis Alberto, Karasik, Avraham, Tangri, Navdeep, Kohsaka, Shun, Kim, Dae Jung, Shaw, Jonathan, Arnold, Suzanne, Goh, Su-Yen, Hammar, Niklas, Fenici, Peter, Bodegård, Johan, Chen, Hungta, Surmont, Filip, Nahrebne, Kyle, Blak, Betina T., Wittbrodt, Eric T., Saathoff, Matthias, Noguchi, Yusuke, Tan, Donna, Williams, Maro, Lee, Hye Won, Greenbloom, Maya, Kaidanovich-Beilin, Oksana, Yeo, Khung Keong, Bee, Yong Mong, Khoo, Joan, Koong, Agnes, Lau, Yee How, Gao, Fei, Tan, Wee Boon, Kadir, Hanis Abdul, Ha, Kyoung Hwa, Lee, Jinhee, Chodick, Gabriel, Melzer Cohen, Cheli, Whitlock, Reid, Cea Soriano, Lucia, Fernándex Cantero, Oscar, Riehle, Ellen, Ilomaki, Jennie, Magliano, Dianna, Lam, Carolyn S.P., Thuresson, Marcus

Publikováno v: In Journal of the American College of Cardiology 12 June 2018 71(23):2628-2639

78 Clinical outcomes in patients with unresectable stage III Non-Small Cell Lung Cancer (NSCLC) treated with durvalumab after chemoradiation in the United Kingdom: CODAK real-world study (NCT04667312)

Autor: Franks, Kevin, Smith, Daniel, Shaw, Paul, Giuseppe Luigi, Banna, Cominos, Mathilda, Talbot, Toby, Blak, Betina T., Lindqvist-Brown, Linnéa, Ahmed, Merina

Publikováno v: In Lung Cancer April 2024 190 Supplement 1

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

SGLT-2 inhibitors and cardiovascular risk: an analysis of CVD-REAL

Autor: Cavender, Matthew A., Norhammar, Anna, Birkeland, Kåre I., Jørgensen, Marit Eika, Wilding, John P., Khunti, Kamlesh, Fu, Alex Z., Bodegard, Johan, Blak, Betina T., Wittbrodt, Eric, Thuresson, Marcus, Fenici, Peter, Hammar, Niklas, Kosiborod, Mikhail

Publikováno v: Cavender, Matthew A. Norhammar, Anna Birkeland, Kåre I. Jørgensen, Marit Eika Wilding, John P. Khunti, Kamlesh Fu, Alex Z. Bodegard, Johan Blak, Betina T. Wittbrodt, Eric Thuresson, Marcus Fenici, Peter Hammar, Niklas Kosiborod, Mikhail . SGLT-2 inhibitors and cardiovascular risk: an analysis of CVD-REAL. Jo
Jo

Externí odkaz: http://hdl.handle.net/10852/66211
https://www.duo.uio.no/bitstream/handle/10852/66211/1/Cavender%2BJACC%2B05.28.18.pdf